Suthee Rapisuwon
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma (NCT03528408) | Suthee Rapisuwon | 2018-07-26 |
Track Suthee Rapisuwon automatically
Every clearance here is in the API, with alerts when new ones post.